摘要
目的:分析耐药肺结核患者治疗结局,从费用补偿角度探究其影响因素。方法:采用描述性分析法分析耐药肺结核患者的费用水平以及补偿情况,采用单因素分析、二元Logistics回归等方法分析患者治疗结局的影响因素。结果:耐药肺结核患者全疗程医疗费用高达69190.88元,实际补偿比为35.62%,有公共卫生项目补助的患者实际补偿比远高于无补助患者,良性结局的患者占64.3%,老年患者、男性患者的治疗结局较差,门诊实际补偿比越高、有公共卫生项目补助、获得医疗救助患者的治疗结局更优。结论:耐药肺结核患者的费用负担较重,可通过提升医保补偿水平、完善项目补助政策、扩大医疗救助覆盖面,提高费用补偿水平,改善患者治疗结局。
Objective To analyze the treatment outcome of patients with drug-resistant pulmonary tuberculosis,and explore the influencing factors from the perspective of cost compensation.Methods Descriptive analysis was used to analyze the cost level and compensation of patients with drug-resistant pulmonary tuberculosis,and univariate analysis and binary logistics regression were used to analyze the influencing factors of treatment outcomes of the patients.Results The total medical treatment cost of patients with drug-resistant pulmonary tuberculosis was as high as 69190.88 yuan,and the actual compensation ratio was 35.62%.The actual compensation ratio of patients with subsidies from special public health programs was much higher than that of patients without subsidies.The benign outcome accounted for 64.3%of the patients,and the treatment outcome of the elderly patients and male patients was significantly worse.The higher actual compensation ratio of the outpatient clinic,the more subsidies of the public health programs,with medical aid,the better treatment outcomes for patients.Conclusion The cost burden of patients with drug-resistant pulmonary tuberculosis is heavy.It is necessary to raise the level of health insurance compensation,improve the program subsidy policy,and expand the coverage of medical aid,so as to increase the level of cost compensation and improve the treatment outcome of patients.
作者
胡鹏
吴成璧
HU Peng;WU Chengbi(Wuhan Red Cross Hospital,Wuhan Hubei 430015,China;不详)
关键词
耐药肺结核
治疗结局
影响因素
医疗保障
drug-resistant pulmonary tuberculosis
treatment outcome
influencing factors
medical security
